Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADVM |
---|---|---|
09:32 ET | 3306 | 6.84 |
09:34 ET | 200 | 6.91 |
09:36 ET | 300 | 6.91 |
09:38 ET | 300 | 6.84 |
09:39 ET | 300 | 6.91 |
09:41 ET | 974 | 6.865 |
09:43 ET | 20139 | 6.93 |
09:45 ET | 6057 | 6.95 |
09:48 ET | 4226 | 6.96 |
09:50 ET | 14623 | 7.03 |
09:52 ET | 900 | 7.05 |
09:54 ET | 700 | 7.005 |
09:56 ET | 300 | 7.005 |
09:57 ET | 800 | 7.01 |
09:59 ET | 1100 | 7.035 |
10:01 ET | 700 | 7.125 |
10:03 ET | 1500 | 7.06 |
10:06 ET | 500 | 7.03 |
10:08 ET | 600 | 6.955 |
10:10 ET | 500 | 6.98 |
10:12 ET | 300 | 6.9 |
10:14 ET | 2711 | 6.935 |
10:15 ET | 3410 | 6.945 |
10:17 ET | 700 | 6.885 |
10:19 ET | 200 | 6.88 |
10:21 ET | 700 | 6.865 |
10:24 ET | 200 | 6.86 |
10:26 ET | 800 | 6.84 |
10:28 ET | 200 | 6.795 |
10:30 ET | 1306 | 6.77 |
10:32 ET | 8153 | 6.78 |
10:33 ET | 500 | 6.77 |
10:35 ET | 400 | 6.755 |
10:37 ET | 1300 | 6.74 |
10:39 ET | 7399 | 6.78 |
10:42 ET | 100 | 6.775 |
10:44 ET | 100 | 6.765 |
10:46 ET | 200 | 6.77 |
10:48 ET | 600 | 6.765 |
10:51 ET | 100 | 6.76 |
10:53 ET | 800 | 6.75 |
10:55 ET | 400 | 6.75 |
10:57 ET | 500 | 6.745 |
11:00 ET | 1300 | 6.73 |
11:02 ET | 1190 | 6.745 |
11:04 ET | 100 | 6.74 |
11:06 ET | 900 | 6.73 |
11:08 ET | 1000 | 6.74 |
11:09 ET | 1200 | 6.73 |
11:11 ET | 3754 | 6.74 |
11:13 ET | 5844 | 6.63 |
11:15 ET | 850 | 6.61 |
11:18 ET | 2456 | 6.68 |
11:20 ET | 200 | 6.68 |
11:22 ET | 100 | 6.64 |
11:24 ET | 900 | 6.695 |
11:26 ET | 200 | 6.68 |
11:27 ET | 100 | 6.61 |
11:29 ET | 800 | 6.66 |
11:33 ET | 400 | 6.66 |
11:36 ET | 1909 | 6.68 |
11:38 ET | 100 | 6.7 |
11:40 ET | 100 | 6.68 |
11:42 ET | 500 | 6.67 |
11:44 ET | 590 | 6.68 |
11:45 ET | 300 | 6.675 |
11:47 ET | 216 | 6.68 |
11:49 ET | 200 | 6.675 |
11:51 ET | 758 | 6.725 |
11:54 ET | 200 | 6.725 |
11:56 ET | 200 | 6.725 |
11:58 ET | 400 | 6.69 |
12:00 ET | 1328 | 6.755 |
12:02 ET | 200 | 6.75 |
12:03 ET | 100 | 6.75 |
12:05 ET | 100 | 6.75 |
12:07 ET | 200 | 6.75 |
12:09 ET | 400 | 6.74 |
12:12 ET | 200 | 6.71 |
12:14 ET | 800 | 6.73 |
12:16 ET | 100 | 6.705 |
12:18 ET | 300 | 6.67 |
12:21 ET | 200 | 6.705 |
12:23 ET | 900 | 6.67 |
12:25 ET | 100 | 6.69 |
12:27 ET | 200 | 6.66 |
12:30 ET | 1400 | 6.68 |
12:32 ET | 200 | 6.68 |
12:34 ET | 300 | 6.68 |
12:36 ET | 100 | 6.68 |
12:38 ET | 200 | 6.67 |
12:39 ET | 200 | 6.67 |
12:41 ET | 300 | 6.66 |
12:43 ET | 502 | 6.7 |
12:45 ET | 300 | 6.685 |
12:48 ET | 1036 | 6.68 |
12:50 ET | 1210 | 6.7 |
12:52 ET | 1211 | 6.72 |
12:54 ET | 100 | 6.755 |
12:57 ET | 200 | 6.755 |
12:59 ET | 100 | 6.755 |
01:01 ET | 811 | 6.765 |
01:03 ET | 400 | 6.76 |
01:06 ET | 1023 | 6.77 |
01:08 ET | 100 | 6.82 |
01:10 ET | 100 | 6.785 |
01:12 ET | 1722 | 6.79 |
01:14 ET | 211 | 6.785 |
01:15 ET | 300 | 6.785 |
01:17 ET | 200 | 6.8 |
01:19 ET | 500 | 6.785 |
01:21 ET | 910 | 6.78 |
01:24 ET | 1723 | 6.785 |
01:28 ET | 1481 | 6.85 |
01:30 ET | 100 | 6.8 |
01:33 ET | 300 | 6.8 |
01:37 ET | 500 | 6.82 |
01:39 ET | 100 | 6.835 |
01:42 ET | 400 | 6.82 |
01:44 ET | 200 | 6.84 |
01:46 ET | 800 | 6.84 |
01:48 ET | 200 | 6.835 |
01:50 ET | 400 | 6.835 |
01:51 ET | 687 | 6.8202 |
01:53 ET | 2209 | 6.86 |
01:55 ET | 1200 | 6.855 |
01:57 ET | 631 | 6.87 |
02:02 ET | 810 | 6.865 |
02:04 ET | 200 | 6.865 |
02:06 ET | 100 | 6.85 |
02:08 ET | 300 | 6.85 |
02:09 ET | 200 | 6.85 |
02:11 ET | 400 | 6.87 |
02:13 ET | 1329 | 6.86 |
02:15 ET | 200 | 6.845 |
02:20 ET | 200 | 6.84 |
02:24 ET | 200 | 6.83 |
02:26 ET | 420 | 6.835 |
02:27 ET | 1100 | 6.85 |
02:29 ET | 100 | 6.865 |
02:31 ET | 200 | 6.85 |
02:33 ET | 300 | 6.9 |
02:36 ET | 2032 | 6.92 |
02:40 ET | 773 | 6.925 |
02:42 ET | 752 | 6.94 |
02:44 ET | 300 | 6.975 |
02:45 ET | 400 | 6.98 |
02:47 ET | 300 | 6.98 |
02:49 ET | 600 | 7.02 |
02:51 ET | 186 | 7.03 |
02:54 ET | 1102 | 6.99 |
02:56 ET | 1100 | 7 |
02:58 ET | 300 | 6.97 |
03:00 ET | 300 | 6.985 |
03:02 ET | 500 | 6.98 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adverum Biotechnologies Inc | 143.4M | -0.7x | --- |
Omega Therapeutics Inc | 132.4M | -1.4x | --- |
Yubo International Biotech Ltd | 145.0M | -119.2x | --- |
Sagimet Biosciences Inc | 132.1M | -3.2x | --- |
INmune Bio Inc | 141.4M | -3.9x | --- |
Invivyd Inc | 144.4M | -0.6x | --- |
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration. Its second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to treat patients suffering from blue cone monochromacy (BCM) via a single IVT injection. It also developing an early-stage pipeline of gene therapy programs.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $143.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 20.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.06 |
EPS | $-10.23 |
Book Value | $8.23 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.